Cat. No. |
Product Name |
CAS No. |
Information |
PC-73373 |
GPS167
|
|
GPS167 is a specific small molecule splicing regulator SRSF10 inhibitor, modulates BCLAF1 splicing with IC50 of 2 uM in human colorectal HCT116 cells, directly inhibits CLK1, CLK2 and CLK4, but not SRPK1 and DYRK1A. |
PC-35987 |
MU1210
|
2275601-87-9 |
MU1210 (MU-1210) is a potent and highly selective inhibitor of cdc-like kinases (CLKs) with IC50 of 51 nM (cellular BRET for CLK1). |
PC-35047 |
T-025
|
|
T-025 (T025, CLK inhibitor T-025) is an orally available, potent inhibitor of Cdc2-like kinases (CLKs) with Kd of 4.8, 0.096, 6.5, and 0.61 nM for CLK1, CLK2, CLK3, and CLK4, also inhibits DYRK1A and DYRK1B with IC50 of 0.074 and 1.5 nM. |
PC-61027 |
SRI-29329
|
2086809-58-5 |
SRI-29329 (SRI29329) is a potent, specific CDC-like kinase (CLK) inhibitor with IC50 of 78, 16 and 86 nM for CLK1, 2 and4, respectively. |
PC-61023 |
TG693
|
885272-55-9 |
TG693 is an orally available, selective, ATP-competitive CLK1 inhibitor with IC50 of 112.6 nM. |
PC-61021 |
CLK inhibitor T3
|
2109805-56-1 |
CLK inhibitor T3 (T3) is a highly potent, selective, and cell-based stable CDC-like kinase (CLK) inhibitor with 0.67, 15 and 110 nM for CLK1,2 and 3, respectively. |
PC-73374 |
CLK4 inhibitor 96
|
500532-67-2 |
CLK4 inhibitor 96 is a novel potent CLK4 inhibitor with IC50 of 57.5 nM. |